Kyprolis is a prescription medication used to treat people with multiple myeloma. It is also approved in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy.
Kyprolis is in a class of medications called proteasome inhibitors. It works by stopping or slowing the growth of cancer cells in your body.
Kyprolis comes as a powder to be mixed with liquid to be injected intravenously (into a vein) by a healthcare professional.
Common side effects include fatigue, anemia, and nausea. Do not drive or operate heavy machinery until you know how this medication affects you.
Cancer [1]
Review Date:
August 6, 2012 Citation:
"Kyprolis", DailyMed: Current Medication Information; U.S. National Library of Medicine [3] “Carfilzomib,” Medline Plus: Current Medication Information; U.S. National Library of Medicine. [4]
Carfilzomib [6]
Photo:
published_note:
RX Label Type:
Long Title:
Kyprolis treats multiple myeloma, a cancer of the bone marrow. Kyprolis may cause extreme tiredness, nausea and anemia. Women should not get pregnant while on this medication. Black Box Warning Image:
Uses Show:
Side Effects Show:
Side Effects Image:
Drug Interactions Show:
Drug Precautions Show:
Food Interactions Show:
Inform MD Show:
Inform MD Image:
Pregnant Show:
Lactation Show:
Drug Usage Show:
Drug Dosage Show:
Overdose Show:
Forms of Medication Show:
Other Requirements Show:
Brand Names Show:
Drug Class Show: